Microheterogeneous monoclonal antibody subspecies with differential hepatitis C virus core antigen binding properties

A Scott Muerhoff1, Kevin Rupprecht, Qiaoqiao Ruan

  • 1Infectious Diseases Research and Development, Abbott Diagnostics, Abbott Laboratories, Abbott Park, IL 60064-6015, USA. scott.muerhoff@abbott.com

Insights

This study reveals that a single monoclonal antibody (mAb) against hepatitis C virus (HCV) core protein comprises distinct subspecies. These subspecies display varied antigen-binding properties due to post-translational modifications, impacting immunoassay performance.

Area of Science:

  • Biochemistry
  • Immunology
  • Analytical Chemistry

Background:

  • Monoclonal antibodies (mAbs) are crucial in immunoassays.
  • Hepatitis C virus (HCV) core protein detection is vital for diagnostics.
  • Characterizing mAb heterogeneity is essential for assay optimization.

Purpose of the Study:

  • To investigate the microheterogeneity of a monoclonal antibody targeting the HCV core protein.
  • To determine the impact of identified subspecies on antigen-binding properties.
  • To assess the utility of this mAb in a sandwich antigen immunoassay.

Main Methods:

  • High-Performance Liquid Chromatography (HPLC) size exclusion chromatography (SEC) using different column matrices and buffer ionic strengths.
  • Isoelectric focusing (IEF) gel electrophoresis.
  • Fluorescence correlation spectroscopy (FCS) for dissociation constant (Kd) measurements.
  • Electrospray Ionization Mass Spectrometry (ESI-MS) for analyzing post-translational modifications.

Main Results:

  • Two distinct IgG subspecies were resolved using methacrylate-based SEC in low ionic strength buffer.
  • These subspecies exhibited differential reactivity towards HCV core antigen.
  • ESI-MS identified unique post-translational modifications (reduction-sensitive and insensitive) on the heavy chain variable regions of one subspecies.
  • FCS revealed differences in Kd values between subspecies in low salt buffer, which diminished in high salt buffer.

Conclusions:

  • The monoclonal antibody is microheterogeneous, composed of subspecies with varying antigen-binding affinities.
  • Post-translational modifications of the heavy chain variable region are associated with these functional differences.
  • The selection of SEC column matrix and buffer conditions is critical for resolving and characterizing mAb subspecies.
  • Understanding mAb heterogeneity is essential for developing robust and reliable diagnostic immunoassays.